Patent · US Active

Matrix metalloproteinase inhibitors

US8343986B2 · kind B2 · utility

0Cited by
4References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2009
Grant dateJan 1, 2013
Priority date—
Expiry dateJan 25, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula (I):pharmaceutically acceptable salts thereof, corresponding preparation processes, pharmaceutical formulations and methods for use as inhibitors of matrix metalloproteinase enzymes (MMPs).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.